FDA inspection
TWi Pharmaceuticals Inc.: FDA inspection ending Mar 27, 2026
FDA inspection 1290528 · No Action Indicated (NAI) · Taipei City
Key facts
| Inspection ID | 1290528 |
|---|---|
| Firm | TWi Pharmaceuticals Inc. |
| FEI number | 3008317961 |
| Address | Neihu Dist. 36, 4 F.; No. 2 Aly.; Ln 26 Ruiguang Rd. |
| City | Taipei City |
| Country | Taiwan |
| Fiscal year | 2026 |
| Inspection end date | Mar 27, 2026 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data